Skip to content

Scope of Homoeopathic medicines in treating cases of Psoriasis vulgaris by using Psoriasis area and severity index scale (PASI)

Scope of Homoeopathic medicines in the management of Psoriasis vulgaris by using Psoriasis area and severity index scale (PASI): An uncontrolled experimental study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085448
Enrollment
30
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: Homoeopathic Medicine: Dose and frequency is a part of management which will vary case to case depending upon the severity and intensity of complaints, hence cannot be commented upon ri

Sponsors

Dr M L Dhawale Memorial Homoeopathic Institute Palghar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: . Patients of all genders ii. Age above 17 years iii. Diagnosed cases as per ICD 10 code L40.0 iv. Patients who are willing to take homoeopathic treatment v. Patient willing to stop external application and steroids at least for 4 weeks of duration before starting homoeopathic treatment vi. Symptoms are persistent even after stopping external application and steroids. vii. Location, sensations, modalities, and concomitants will be assessed carefully of previous 1 year for the presence of any remissions or seasonal modalities.

Exclusion criteria

Exclusion criteria: . Pregnant and lactating patients ii. Patient suffering from any other skin condition like Tinea, Eczema along with psoriasis iii. Patient developing complications of psoriasis like pustular psoriasis, psoriatic arthritis, acute fulminant psoriasis, etc. iv. Uncontrolled DM

Design outcomes

Primary

MeasureTime frame
To assess the role of Homoeopathic medicines in reducing the severity and disease surface area in psoriasis vulgaris assessed with the help of the PASI scale within 6 months of period.Timepoint: 1.5 YEARS

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Shama Rao

DR.M.L.DHAWALE MEMORIAL HOMOEOPATHIC INSTITUTE

rao.shama@rediffmail.com9892212843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026